Shortcast: Clinical Outcomes in Hydroxocobalamin-Treated Patients With Early-Onset Cobalamin C Disease
About this episode
Arty Selvanathan discusses a study on clinical outcomes and biochemical findings in cobalamin C disease.
In this JIMD Shortcast, first author Arty Selvanathan discusses their study exploring how clinical outcomes relate to biochemical findings in cobalamin C (cblC) disease. What can biochemical markers really tell us about disease severity, and where do their limitations lie? Clinical Outcomes and Correlation With Biochemical Control in Hydroxocobalamin-Treated Patients With Early-Onset Cobalamin C Disease Arthavan Selvanathan, et al https://doi.org/10.1002/jmd2.70091
More episodes of JIMD Podcasts
- Hidden Disease or Uncertain Risk? Rethinking IMD Diagnosis and Newborn Screening
- IMD Research Round-Up: Phenylketonuria
- Rapamycin and Pharmacogenomics in Niemann-Pick C
- Feeding the Microbiome: Rethinking Protein and Propionate in MMA
- Shortcast: Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB
Explore listener stats, chart rankings, contacts and more on the JIMD Podcasts podcast page.